Jarmalaite S - Search Results

1

Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma.

Lemeta S, Jarmalaite S, Pylkkänen L, Böhling T, Husgafvel-Pursiainen K. Lemeta S, et al. Among authors: jarmalaite s. J Neuropathol Exp Neurol. 2007 Sep;66(9):860-7. doi: 10.1097/nen.0b013e318149ee64. J Neuropathol Exp Neurol. 2007. PMID: 17805016

2

Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.

Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K. Jarmalaite S, et al. Int J Cancer. 2003 Oct 10;106(6):913-8. doi: 10.1002/ijc.11322. Int J Cancer. 2003. PMID: 12918069

3

CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.

Wikman H, Nymark P, Väyrynen A, Jarmalaite S, Kallioniemi A, Salmenkivi K, Vainio-Siukola K, Husgafvel-Pursiainen K, Knuutila S, Wolf M, Anttila S. Wikman H, et al. Among authors: jarmalaite s. Genes Chromosomes Cancer. 2005 Feb;42(2):193-9. doi: 10.1002/gcc.20122. Genes Chromosomes Cancer. 2005. PMID: 15543620

4

Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.

Jarmalaite S, Jankevicius F, Kurgonaite K, Suziedelis K, Mutanen P, Husgafvel-Pursiainen K. Jarmalaite S, et al. Oncology. 2008;75(3-4):145-51. doi: 10.1159/000158665. Epub 2008 Sep 29. Oncology. 2008. PMID: 18824877

5

Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.

Jarmalaite S, Laurinaviciene A, Tverkuviene J, Kalinauskaite N, Petroska D, Böhling T, Husgafvel-Pursiainen K. Jarmalaite S, et al. Cancer Genet. 2011 Jul;204(7):398-404. doi: 10.1016/j.cancergen.2011.07.002. Cancer Genet. 2011. PMID: 21872827

6

Asbestos-associated genome-wide DNA methylation changes in lung cancer.

Kettunen E, Hernandez-Vargas H, Cros MP, Durand G, Le Calvez-Kelm F, Stuopelyte K, Jarmalaite S, Salmenkivi K, Anttila S, Wolff H, Herceg Z, Husgafvel-Pursiainen K. Kettunen E, et al. Among authors: jarmalaite s. Int J Cancer. 2017 Nov 15;141(10):2014-2029. doi: 10.1002/ijc.30897. Epub 2017 Aug 2. Int J Cancer. 2017. PMID: 28722770

7

Frequent DNA methylation changes in cancerous and noncancerous lung tissues from smokers with non-small cell lung cancer.

Daniunaite K, Sestokaite A, Kubiliute R, Stuopelyte K, Kettunen E, Husgafvel-Pursiainen K, Jarmalaite S. Daniunaite K, et al. Among authors: jarmalaite s. Mutagenesis. 2020 Sep 11:geaa022. doi: 10.1093/mutage/geaa022. Online ahead of print. Mutagenesis. 2020. PMID: 32914849

8

Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study.

Jarmalaite S, Andrekute R, Scesnaite A, Suziedelis K, Husgafvel-Pursiainen K, Jankevicius F. Jarmalaite S, et al. J Cancer Res Clin Oncol. 2010 Jun;136(6):847-54. doi: 10.1007/s00432-009-0725-y. Epub 2009 Nov 19. J Cancer Res Clin Oncol. 2010. PMID: 19924441 Clinical Trial.

9

Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.

Daniūnaitė K, Berezniakovas A, Jankevičius F, Laurinavičius A, Lazutka JR, Jarmalaitė S. Daniūnaitė K, et al. Among authors: jarmalaite s. Medicina (Kaunas). 2011;47(3):147-53. Medicina (Kaunas). 2011. PMID: 21822036 English, Lithuanian.

10

High-resolution melting-based quantitative analysis of RASSF1 methylation in breast cancer.

Stuopelytė K, Daniūnaitė K, Laurinavičienė A, Ostapenko V, Jarmalaitė S. Stuopelytė K, et al. Among authors: jarmalaite s. Medicina (Kaunas). 2013;49(2):78-83. Medicina (Kaunas). 2013. PMID: 23888343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results